Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of efficacy and safety of lascufloxacin for nursing and healthcare associated pneumonia: single-arm, open-label clinical trial: A study protocol.
Hosogaya N, Takazono T, Ota K, Kiya R, Shirai Y, Kawasaki R, Yano H, Morimoto S, Nakao R, Kanamaru Y, Yoshino Y, Ishikawa Y, Fukushima C, Yamamoto H, Izumikawa K, Yanagihara K, Mukae H. Hosogaya N, et al. Medicine (Baltimore). 2023 Feb 22;102(8):e33092. doi: 10.1097/MD.0000000000033092. Medicine (Baltimore). 2023. PMID: 36827005 Free article.
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Tashiro M, Izumikawa K, Minematsu A, Hirano K, Iwanaga N, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S. Tashiro M, et al. Among authors: hosogaya n. Antimicrob Agents Chemother. 2012 Jan;56(1):584-7. doi: 10.1128/AAC.05394-11. Epub 2011 Oct 24. Antimicrob Agents Chemother. 2012. PMID: 22024829 Free PMC article.
A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin.
Yamamoto Y, Izumikawa K, Hosogaya N, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Sakamoto N, Ishimatu Y, Kakeya H, Yanagihara K, Yasuoka A, Kohno S. Yamamoto Y, et al. Among authors: hosogaya n. Intern Med. 2012;51(11):1383-6. doi: 10.2169/internalmedicine.51.6985. Epub 2012 Jun 1. Intern Med. 2012. PMID: 22687847 Free article.
Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.
Tashiro M, Izumikawa K, Hirano K, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S. Tashiro M, et al. Among authors: hosogaya n. Antimicrob Agents Chemother. 2012 Sep;56(9):4870-5. doi: 10.1128/AAC.00514-12. Epub 2012 Jul 2. Antimicrob Agents Chemother. 2012. PMID: 22751542 Free PMC article.
Active Surveillance of Methicillin-Resistant Staphylococcus aureus Using a Fully Automated Molecular Test in an Emergency Medical Center.
Morinaga Y, Yamano S, Akamatsu N, Kaku N, Nagaoka K, Migiyama Y, Harada Y, Hosogaya N, Yamamoto Y, Tasaki O, Yanagihara K, Kohno S. Morinaga Y, et al. Among authors: hosogaya n. Jpn J Infect Dis. 2015;68(5):376-80. doi: 10.7883/yoken.JJID.2014.352. Epub 2015 Mar 13. Jpn J Infect Dis. 2015. PMID: 25766607 Free article.
An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial.
Koga T, Hagimori N, Sato S, Morimoto S, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Jan;99(1):e18328. doi: 10.1097/MD.0000000000018328. Medicine (Baltimore). 2020. PMID: 31895769 Free PMC article.
Discrepancies in preferences regarding the care of terminal-phase pneumonia in elderly patients among patients, families, and doctors: A multicenter questionnaire survey in nagasaki, Japan.
Takazono T, Imamura Y, Kawakami K, Yamasaki N, Shimizu H, Usuki K, Kiyohara M, Hirayama T, Tashiro M, Hosogaya N, Saijo T, Yamamoto K, Miyazaki T, Yanagihara K, Izumikawa K, Mukae H. Takazono T, et al. Among authors: hosogaya n. Respir Investig. 2020 Nov;58(6):488-494. doi: 10.1016/j.resinv.2020.05.003. Epub 2020 Jul 3. Respir Investig. 2020. PMID: 32631765
Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): Study protocol for an interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments.
Shimizu T, Kawashiri SY, Sato S, Morimoto S, Minoda S, Kawazoe Y, Kuroda S, Tashiro S, Sumiyoshi R, Hosogaya N, Yamamoto H, Kawakami A. Shimizu T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Aug 7;99(32):e21480. doi: 10.1097/MD.0000000000021480. Medicine (Baltimore). 2020. PMID: 32769882 Free PMC article.
Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease: Study protocol for clinical trial.
Koga T, Hagimori N, Takemori S, Morimoto S, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Kawakami A. Koga T, et al. Among authors: hosogaya n. Medicine (Baltimore). 2020 Jul 24;99(30):e20710. doi: 10.1097/MD.0000000000020710. Medicine (Baltimore). 2020. PMID: 32791665 Free PMC article.
46 results